Strata Skin Sciences, Inc.
SSKN
$2.89
$0.2911.15%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -0.62% | 2.24% | -10.74% | -18.04% | -5.96% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.62% | 2.24% | -10.74% | -18.04% | -5.96% |
| Cost of Revenue | -10.47% | -11.04% | 15.57% | 3.57% | 7.86% |
| Gross Profit | 7.13% | 14.34% | -29.81% | -29.89% | -14.57% |
| SG&A Expenses | 26.24% | -11.55% | -13.98% | -11.08% | -16.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.38% | -12.64% | -5.02% | -5.94% | -7.18% |
| Operating Income | -168.78% | 75.23% | -11.72% | -963.43% | 21.76% |
| Income Before Tax | -101.52% | 96.86% | -18.80% | -3,906.19% | -5.83% |
| Income Tax Expenses | -- | -- | -- | -246.03% | -- |
| Earnings from Continuing Operations | -101.52% | 96.86% | -18.80% | -2,271.25% | -5.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -101.52% | 96.86% | -18.80% | -2,271.25% | -5.83% |
| EBIT | -168.78% | 75.23% | -11.72% | -963.43% | 21.76% |
| EBITDA | -149.64% | 243.07% | -37.93% | -91.62% | 58.86% |
| EPS Basic | -74.20% | 96.88% | -18.13% | -2,249.89% | -5.23% |
| Normalized Basic EPS | -74.22% | 57.20% | -18.12% | -1,533.71% | -5.25% |
| EPS Diluted | -74.20% | 96.88% | -18.13% | -2,249.89% | -5.23% |
| Normalized Diluted EPS | -74.22% | 57.20% | -18.12% | -1,533.71% | -5.25% |
| Average Basic Shares Outstanding | 15.69% | 0.51% | 0.57% | 0.87% | 0.54% |
| Average Diluted Shares Outstanding | 15.69% | 0.51% | 0.57% | 0.87% | 0.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
